IRONWOOD PHARMACEUTICALS, INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2016 | — | $66.7M | $54.0M |
| FY2017 | — | $9.8M | $125.7M |
| FY2018 | — | $-196.4M | $173.2M |
| FY2019 | — | $-93.3M | $177.0M |
| FY2020 | $430.3M | $62.6M | $362.6M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2016 | — | $66.7M | $54.0M |
| FY2017 | — | $9.8M | $125.7M |
| FY2018 | — | $-196.4M | $173.2M |
| FY2019 | — | $-93.3M | $177.0M |
| FY2020 | $430.3M | $62.6M | $362.6M |